Yumanity Therapeutics Inc (NASDAQ:YMTX)
| 1.58 Delayed Data As of Sep 30 |  -0.04 / -2.47%Today’s Change | 0.95 Today|||52-Week Range 10.62 | -46.62% Year-to-Date |
Latest YMTX News | Press Releases
No recent news for Yumanity Therapeutics Inc.
Today’s Trading
| Previous close | 1.62 |
| Today’s open | 1.59 |
| Day’s range | 1.56 - 1.59 |
| Volume | 243 |
| Average volume (3 months) | 843,731 |
| Market cap | $17.3M |
Data as of 11:42am ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +82.19% |
| Earnings growth (this year) | -8.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +16.65% |
| P/E ratio | NM |
| Price/Sales | 3.78 |
| Price/Book | 0.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EVFMEvofem Biosciences I... | -0.01 | -6.74% |
| ONVOOrganovo Holdings In... | -0.09 | -4.21% |
| GENEGenetic Technologies... | +0.01 | +1.23% |
| CBIOCatalyst Biosciences... | -0.00 | -0.90% |
Data as of 4:01pm ET, 09/30/2022
Financials
| Next reporting date | November 14, 2022 |
| EPS forecast (this quarter) | -$1.08 |
| Annual revenue (last year) | $8.0M |
| Annual profit (last year) | -$39.5M |
| Net profit margin | -491.09% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
